E21.3 - Hyperparathyroidism, unspecified
ICD-10: | E21.3 |
Short Description: | Hyperparathyroidism, unspecified |
Long Description: | Hyperparathyroidism, unspecified |
Status: | Valid for Submission |
Version: | ICD-10-CM 2023 |
Code Classification: |
E21.3 is a billable ICD-10 code used to specify a medical diagnosis of hyperparathyroidism, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
Unspecified diagnosis codes like E21.3 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Brown tumor of hyperparathyroidism
- Calcifying panniculitis due to hyperparathyroidism
- Hyperparathyroidism
- Myopathy in hyperparathyroidism
- Neonatal hyperparathyroidism
- Subcutaneous calcification
Clinical Information
- Hyperparathyroidism-. a condition of abnormally elevated output of parathyroid hormone (or pth) triggering responses that increase blood calcium. it is characterized by hypercalcemia and bone resorption, eventually leading to bone diseases. primary hyperparathyroidism is caused by parathyroid hyperplasia or parathyroid neoplasms. secondary hyperparathyroidism is increased pth secretion in response to hypocalcemia, usually caused by chronic kidney diseases.
- Hyperparathyroidism, Primary-. a condition of abnormally elevated output of parathyroid hormone due to parathyroid hyperplasia or parathyroid neoplasms. it is characterized by the combination of hypercalcemia, phosphaturia, elevated renal 1,25-dihydroxyvitamin d3 synthesis, and increased bone resorption.
- Hyperparathyroidism, Secondary-. abnormally elevated parathyroid hormone secretion as a response to hypocalcemia. it is caused by chronic kidney failure or other abnormalities in the controls of bone and mineral metabolism, leading to various bone diseases, such as renal osteodystrophy.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Arthritis, arthritic (acute) (chronic) (nonpyogenic) (subacute) - M19.90
- - in (due to)
- - hyperparathyroidism NEC - See Also: subcategory M14.8-; - E21.3
- - in (due to)
- - Arthropathy - See Also: Arthritis; - M12.9
- - hemophilic NEC - D66
- - in (due to)
- - hyperparathyroidism NEC - E21.3
- - in (due to)
- - hemophilic NEC - D66
- - Hyperfunction
- - parathyroid (gland) - E21.3
- - Hyperparathyroidism - E21.3
- - Myopathy - G72.9
- - in (due to)
- - hyperparathyroidism NEC - E21.3
- - in (due to)
Convert to ICD-9 Code
Source ICD-10 Code | Target ICD-9 Code | |
---|---|---|
E21.3 | 252.00 - Hyperparathyroidism NOS |
Patient Education
Parathyroid Disorders
Most people have four pea-sized glands, called parathyroid glands, on the thyroid gland in the neck. Though their names are similar, the thyroid and parathyroid glands are completely different. The parathyroid glands make parathyroid hormone (PTH), which helps your body keep the right balance of calcium and phosphorous.
If your parathyroid glands make too much or too little hormone, it disrupts this balance. If they secrete extra PTH, you have hyperparathyroidism, and your blood calcium rises. In many cases, a benign tumor on a parathyroid gland makes it overactive. Or, the extra hormones can come from enlarged parathyroid glands. Very rarely, the cause is cancer.
If you do not have enough PTH, you have hypoparathyroidism. Your blood will have too little calcium and too much phosphorous. Causes include injury to the glands, endocrine disorders, or genetic conditions. Treatment is aimed at restoring the balance of calcium and phosphorous.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)